Company: VERA
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103022
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
31, 2024, respectively

     64

     64

     Additional paid-in capital

     1,057,161

     1,037,948

     Accumulated other comprehensive income

     527

     393

     Accumulated deficit

     (589,475
     )

     (461,250
     )

     Total stockholders’ equity

     468,277

     577,155

     Total liabilities and stockholders’ equity
      
     $
     578,528

     $
     655,681

The accompanying notes are an integral part of these unaudited condensed financial statements.